Supplementary Material for: Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease by Fabbrocini G. (7463126)

“…<b><i>Objective:</i></b> To evaluate how the burden of HS disease impacts on patient well-being and working activities in a large Italian population over a period of 9 months. …”

Image_1_Comparison of first-line treatments for elderly patients with diffuse large B-cell lymphoma: A systematic review and network meta-analysis.tif by Yangyang Wang (642852)

Table_1_Comparison of first-line treatments for elderly patients with diffuse large B-cell lymphoma: A systematic review and network meta-analysis.docx by Yangyang Wang (642852)

Presentation 1_Tracking priming-induced language recovery in aphasia with pre-trained language models.zip by Yan Cong (1491478)

Data Sheet 1_Tracking priming-induced language recovery in aphasia with pre-trained language models.zip by Yan Cong (1491478)

Average self-reported physical health ratings before or during the COVID-19 pandemic among individuals who engaged during the pandemic in more than 3 (A), 4 (B), or 5 (C) positive... by Elie Mulhem (22537863)

A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas by L. E. van der Meeren (7490675)

“…<div><p>Diffuse large B-cell lymphoma—not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgroup of non-Hodgkin lymphoma. …”

Table_2_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf by Tianqi Xu (9574329)

“…Background<p>Anaplastic diffuse large B-cell lymphoma(A-DLBCL) is a rare morphological subtype characterized by the presence of polygonal, bizarre-shaped tumor cells. …”

Table_1_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf by Tianqi Xu (9574329)

“…Background<p>Anaplastic diffuse large B-cell lymphoma(A-DLBCL) is a rare morphological subtype characterized by the presence of polygonal, bizarre-shaped tumor cells. …”

Summary estimate for the pooled PLR (A) and NLR (B) of MPV in the diagnosis of ITP. by Muluken Walle (13794209)

Diversity, distribution and dynamics of large trees across an old-growth lowland tropical rain forest landscape by David B. Clark (7846700)

Effects of increased epithelial cell contractility on the large intestine. by Taylor Hinnant (18239604)

K2 increases intracellular killing of <i>K</i>. <i>pneumoniae</i> by <i>kil1</i> KO and <i>kil2</i> KO cells. by Estelle Ifrid (10076719)

Subjects:

Expression of lipid biosynthetic genes is decreased with polyamine depletion. by Yazmin E. Cruz-Pulido (20285238)

VOC Alpha spike protein shows decreased proteolytic processing. by Daniela Niemeyer (199082)

WT host survival decreased with STAT6 KO-adapted <i>N</i>. <i>brasiliensis</i> infection. by Annabel A. Ferguson (17616286)

<i>vFlip</i> expression largely protects from lethality induced by <i>cFlip</i> deletion. by Barbara Ruder (8379354)

Table1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.docx by Chaofeng Zhang (845343)

“…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …”

Image1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG by Chaofeng Zhang (845343)

“…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …”

Image2_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG by Chaofeng Zhang (845343)

“…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …”